R&D

News

HHS details plan to regain the US's edge in clinical trials

The US launches a concerted effort to "restore American leadership in clinical trials" as it deals with the emergence of China as a global R&D hub.

News

Sanofi names ex-Roche exec Fontoura as R&D chief

Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houmab Ashrafian as Sanofi's R&D head on 1st September.

R&D

Clinical Trials Round-Up: March and April 2026

March and April offered no shortage of talking points for the clinical trials community.

News

Meet Dalton, a new AI-powered drug discovery platform

Just a few months after emerging from stealth, the UK's DaltonTx has launched its AI in drug discovery platform and revealed its first client.

News

Innovent in line for $10.5bn in Pfizer cancer alliance

Pfizer has signed a strategic-level alliance with Innovent, worth $10.5bn and spanning 12 cancer assets, in another sign of China's rising R&D status.

News

Bristol Myers Squibb and Hengrui Pharma logos

BMS signs $15.2bn R&D alliance with China's Hengrui

Hengrui agrees a $15.2bn R&D alliance with BMS in oncology/haematology and immunology, less than a year after a similar $12bn deal with GSK.

HHS details plan to regain the US's edge in clinical trials

Sanofi names ex-Roche exec Fontoura as R&D chief

Clinical Trials Round-Up: March and April 2026

Meet Dalton, a new AI-powered drug discovery platform

Innovent in line for $10.5bn in Pfizer cancer alliance

BMS signs $15.2bn R&D alliance with China's Hengrui

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

R&D

Editor's Picks